Please enable Javascript to use all features and improve your user experience.
ST Herbst 2022 der DGNC
Programme
People
Search
DE
Back
Sektion Neuroonkologie
Neuroonkologie
Molekulare Diagnostik und Therapie II
Appointment
Date:
28/10/2022
Time:
11:15
–
12:45
Location / Stream:
Saal B
Vorsitz
Marco Stein
Gießen
Niklas Thon
München
Programme
11:15
–
11:55
40 Min.
0 Min.
Vortrag
Molekulare Diagnostik
Till Acker (Gießen)
11:55
–
12:05
7 Min.
3 Min.
Abstractvortrag
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy – the MecMeth/NOA-24 trial study protocol
Matthias Schneider (Bonn)
12:05
–
12:15
7 Min.
3 Min.
Abstractvortrag
Resection of recurrent intracranial tumors for molecular diagnostics in the age of precision oncology: A risk-benefit analysis
Obada T. Alhalabi (Heidelberg)
12:15
–
12:25
7 Min.
3 Min.
Abstractvortrag
Dual CAR-T cell approach in ex vivo glioblastoma models: A new approach to overcome antigen escape mechanisms
Marah Alsalkini (Würzburg)
12:25
–
12:35
7 Min.
3 Min.
Abstractvortrag
CMV induced MGMT upregulation leads to resistance to alkylating chemotherapy and shortened overall survival in glioblastoma – A prospective, single center observational trial
Harald Krenzlin (Mainz)
Naureen Keric (Mainz)
12:35
–
12:45
7 Min.
3 Min.
Abstractvortrag
Preoperative risk stratification of increased MIB-1 labeling index in pituitary adenoma: A newly proposed prognostic scoring system
Ivan Maiseyeu (Bonn)
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy